Assessing forearm fracture risk in postmenopausal women

Low bone mass--assessing absolute fracture risk and the need to treat younger postmenopausal women.

The need to initiate treatment for a postmenopausal woman with a low bone mass should be based on that individual's fracture risk over a fnite period of time. Fracture assessment tools, such as the recently introduced FRAX(TM) model, allows the clinician to estimate an individual's absolute fracture risk over the next decade of their life. Such estimates are particularly useful for younger post...

Homocysteine levels and risk of hip fracture in postmenopausal women.

BACKGROUND Recent studies suggest that high homocysteine levels are associated with an increased risk of fractures. Homocysteine levels are known to be influenced by vitamin B and folate supply or status, and poor renal function can result in higher levels independent of nutritional adequacy. OBJECTIVE The aim of the study was to determine the associations between fasting homocysteine levels ...

Gene-Hormone Therapy Interaction and Fracture Risk in Postmenopausal Women.

Context Evidence supports a protective effect of menopausal hormone therapy (HT) on bone. However, whether genetic susceptibility modifies the association of HT and fracture risk is not sufficiently explored. Objective The objective was to test an interaction between genetic susceptibility and HT on fracture risk. Design We constructed two weighted genetic risk scores (GRSs) based on 16 fra...

Estrogen plus progestin reduced risk for fracture in postmenopausal women.

Ovarian Torsion in Postmenopausal Women and risk of malignancy

Background & aim: Ovarian torsion is one of the most common causes of emergency surgery in gynecology, with a tendency to occur in postmenopausal women. The aim of this study was to provide information concerning the clinical presentations, surgical management, pathological findings and risk of malignancy in postmenopausal women with ovarian torsion. Methods:In this cross-sectional study, the r...